ACTIVE

ANTHA CONSULT

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-49,3 k €

-37.0% YoY

Gross margin

-4,3 k €

-136.6% YoY

Equity

17,6 k €

-73.7% YoY

Workforce

0,6 ETP

0.0% YoY

What does ANTHA CONSULT do?

ANTHA CONSULT is a Private limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Liège. It employs on average 0,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0479.479.215

Incorporation

06/02/2003

Legal form

Private limited company

Registered office

Rue Louvrex 56
4000 Liège · WallonieSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Average workforce

0,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 70200Management consultancy activities 70220Business and other management consultancy activities 74142Specialised design activities+6

Joint committees (1)

Contacts

1 public detail availableLog in to view

Signals

Healthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	-4,3 k €	-137%	11,8 k €	-85.7%	82,4 k €	+79.7%	45,9 k €	-2.4%	47 k €	+173%	17,2 k €	-46.8%	32,3 k €	-36.0%	50,5 k €	-21.1%	64,1 k €	-13.0%	73,7 k €	+1.9%	72,3 k €	-22.9%	93,7 k €	-0.8%	94,5 k €	+18.6%	79,6 k €	-25.0%	106,2 k €	+27.3%	83,4 k €	-18.0%	101,7 k €	-23.5%	132,9 k €	+34.7%	98,6 k €	+53.7%	64,1 k €
EBITDA	-40,5 k €	-48.3%	-27,3 k €	-154%	50,6 k €	+141%	21 k €	-29.4%	29,7 k €	+304%	-14,5 k €	-243%	10,2 k €	-54.0%	22,2 k €	-41.9%	38,1 k €	-41.6%	65,2 k €	-3.9%	67,9 k €	-16.3%	81,2 k €	+10.3%	73,6 k €	-3.8%	76,4 k €	-25.0%	102 k €	+101%	50,9 k €	-33.3%	76,3 k €	-26.4%	103,7 k €	+29.6%	80 k €	+32.7%	60,3 k €
Operating result	-45,4 k €	-40.9%	-32,2 k €	-172%	44,9 k €	+494%	7,6 k €	-53.9%	16,4 k €	+159%	-27,7 k €	-341%	-6,3 k €	-223%	5,1 k €	-70.9%	17,6 k €	-57.5%	41,3 k €	+12.7%	36,6 k €	-26.4%	49,7 k €	+20.3%	41,4 k €	-10.6%	46,3 k €	-37.1%	73,6 k €	+224%	22,7 k €	-51.3%	46,7 k €	-37.6%	74,8 k €	+44.2%	51,8 k €	+83.4%	28,3 k €
Net result	-49,3 k €	-37.0%	-36 k €	-198%	36,9 k €	+800%	4,1 k €	-62.1%	10,8 k €	+130%	-35,5 k €	-206%	-11,6 k €	-1061%	1,2 k €	-86.0%	8,6 k €	-65.0%	24,7 k €	+14.1%	21,6 k €	-27.7%	29,9 k €	+24.7%	24 k €	-5.6%	25,4 k €	-45.1%	46,3 k €	+361%	10 k €	-59.7%	24,9 k €	-33.7%	37,6 k €	-6.0%	40 k €	+189%	13,8 k €
Balance sheet
Equity	17,6 k €	-73.7%	67 k €	-35.0%	103 k €	+28.5%	80,1 k €	+5.4%	76 k €	+16.6%	65,2 k €	-35.2%	100,7 k €	-10.3%	112,3 k €	+0.2%	112 k €	-38.6%	182,4 k €	+14.6%	159,2 k €	+14.5%	139,1 k €	+34.0%	103,8 k €	-5.5%	109,8 k €	-4.0%	114,4 k €	+67.9%	68,1 k €	+0.1%	68,1 k €	+57.8%	43,2 k €	-31.6%	63,1 k €	+174%	23,1 k €
Total assets	272,1 k €	-10.2%	302,9 k €	-13.7%	351,1 k €	-16.6%	421,2 k €	+28.2%	328,5 k €	+1.5%	323,8 k €	+23.1%	263 k €	-19.5%	326,7 k €	-21.5%	416 k €	-7.3%	448,6 k €	+5.6%	424,8 k €	+12.8%	376,6 k €	+2.7%	366,8 k €	-6.0%	390,1 k €	-1.7%	396,9 k €	-1.7%	403,7 k €	-4.8%	423,9 k €	-8.5%	463,1 k €	+16.0%	399,1 k €	-4.7%	418,8 k €
Cash	10,8 k €	-11.1%	12,1 k €	-60.2%	30,5 k €	+16.9%	26,1 k €	-18.6%	32,1 k €	+131%	13,9 k €	-74.8%	55,1 k €	-2.9%	56,7 k €	-49.5%	112,4 k €	-3.3%	116,2 k €	+33.0%	87,4 k €	-3.2%	90,2 k €	-12.4%	102,9 k €	+34.7%	76,4 k €	-16.5%	91,4 k €	+0.3%	91,1 k €	-1.7%	92,7 k €	+27.0%	73 k €	+338%	16,7 k €	-39.7%	27,7 k €
Debts	245,8 k €	+11.0%	221,4 k €	-5.6%	234,5 k €	+20.8%	194,2 k €	-20.6%	244,6 k €	-3.5%	253,3 k €	+62.3%	156,1 k €	-26.7%	213,1 k €	-29.6%	302,9 k €	+14.3%	265 k €	+0.7%	263,1 k €	+11.5%	235,9 k €	-9.9%	261,9 k €	-6.3%	279,7 k €	-0.5%	281,2 k €	-15.4%	332,5 k €	-6.1%	354,1 k €	-15.3%	417,8 k €	+25.0%	334,3 k €	-15.1%	393,7 k €
Other
Workforce	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	+20.0%	0,5 ETP	+25.0%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP		–		0,5 ETP	+400%	0,1 ETP		–		0,3 ETP	-50.0%	0,6 ETP		–		–		0,8 ETP	0.0%	0,8 ETP	+100%	0,4 ETP	0.0%	0,4 ETP	+300%	0,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

SOPHARMA MANAGEMENT

Director · since 16 septembre 2020 · 0729.706.947

Represented by Oudkerk Sophie

Active

Ended mandates

SOPHARMA MANAGEMENT

Director · since 16 septembre 2020 · 0729.706.947

Represented by Oudkerk SOPHIE

Ended

SOPHARMA MANAGEMENT

Director · since 16 septembre 2020 · 0729.706.947

Represented by Oudkerk SOPHIE

Ended

Nathalie VAN WEERT

Manager

Ended

SOPHARMA MANAGEMENT

Director · 0729.706.947

Represented by Sophie Oudkerk

Ended

At this address

Other companies at this address

Company	CBE no.
SOPHARMA MANAGEMENT● Active	0729.706.947

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/08/2026	27/08/2025	23/08/2024	31/08/2023	31/08/2022	16/08/2021
General meeting	05/06/2026	06/06/2025	07/06/2024	02/06/2023	03/06/2022	04/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	05/06/2026	14/08/2026	French	PDF
Abridged model	31/12/2024	06/06/2025	27/08/2025	French	PDF
Abridged model	31/12/2023	07/06/2024	23/08/2024	French	PDF
Abridged model	31/12/2022	02/06/2023	31/08/2023	French	PDF
Abridged model	31/12/2021	03/06/2022	31/08/2022	French	PDF
Abridged model	31/12/2020	04/06/2021	16/08/2021	French	PDF
Abridged model	31/12/2019	31/08/2020	15/09/2020	French	PDF
Micro model	31/12/2018	21/05/2019	18/06/2019	French	PDF
Abridged model	31/12/2017	24/04/2018	23/05/2018	French	PDF
Abridged model	31/12/2016	13/06/2017	21/06/2017	French	PDF
Abridged model	31/12/2015	17/06/2016	30/07/2016	French	PDF
Abridged model	31/12/2014	30/06/2015	30/07/2015	French	PDF
Abridged model	31/12/2013	17/04/2014	07/05/2014	French	PDF
Abridged model	31/12/2012	25/06/2013	24/07/2013	French	PDF
Abridged model	31/12/2011	01/06/2012	19/06/2012	French	PDF
Abridged model	31/12/2010	03/06/2011	15/06/2011	French	PDF
Abridged model	31/12/2009	04/06/2010	29/06/2010	French	PDF
Abridged model	31/12/2008	31/03/2009	22/04/2009	French	PDF
Abridged model	31/12/2007	06/06/2008	30/06/2008	French	PDF
Abridged model	31/12/2006	01/06/2007	13/06/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

SOPHARMA MANAGEMENT

Director · since 16 septembre 2020 · 0729.706.947

Represented by Oudkerk Sophie

Active

Ended mandates

SOPHARMA MANAGEMENT

Director · since 16 septembre 2020 · 0729.706.947

Represented by Oudkerk SOPHIE

Ended

SOPHARMA MANAGEMENT

Director · since 16 septembre 2020 · 0729.706.947

Represented by Oudkerk SOPHIE

Ended

Nathalie VAN WEERT

Manager

Ended

SOPHARMA MANAGEMENT

Director · 0729.706.947

Represented by Sophie Oudkerk

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates23/09/2020
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates09/10/2019
DEMISSIONS, NOMINATIONS
PDF
Registered office17/09/2009
SIEGE SOCIAL
PDF
Capital / shares27/04/2005
OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - ASSEMBLEE GENERALE - CAPITAL, ACTIONS
PDF
Registered office26/05/2003
SIEGE SOCIAL
PDF
Other14/02/2003
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-49,3 k €↓
2024
Annual accounts 2024-36 k €↓
2023
Annual accounts 202336,9 k €↑
2022
Annual accounts 20224,1 k €↓
2021
Annual accounts 202110,8 k €↑
2020
Annual accounts 2020-35,5 k €↓
2019
Annual accounts 2019-11,6 k €↓
2018
Annual accounts 20181,2 k €↓
2017
Annual accounts 20178,6 k €↓
2016
Annual accounts 201624,7 k €↑
2015
Annual accounts 201521,6 k €↓
2014
Annual accounts 201429,9 k €↑
2013
Annual accounts 201324 k €↓
2012
Annual accounts 201225,4 k €↓
2011
Annual accounts 201146,3 k €↑
2010
Annual accounts 201010 k €↓
2009
Annual accounts 200924,9 k €↓
2008
Annual accounts 200837,6 k €↓
2007
Annual accounts 200740 k €↑
2006
Annual accounts 200613,8 k €
06/02/2003
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ANTHA CONSULT

Overview

What does ANTHA CONSULT do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline